Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma
JCO Precision Oncology · 2024
DOI: 10.1200/po.23.00368 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von Takuto Sato und 14 weiteren Autor:innen. Beteiligte Einrichtung: Broad Institute of MIT and Harvard, Boston, MA. Hauptthemen laut MEDLINE: Melanoma, Circulating Tumor DNA, Uveal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Somatic chromosomal alterations, particularly monosomy 3 and 8q gains, have been associated with metastatic risk in uveal melanoma (UM). Whole genome-scale evaluation of detectable alterations in cell-free DNA (cfDNA) in UM could provide valuable prognostic information. Our pilot study evaluates the correlation between genomic information using ultra-low-pass whole-genome sequencing (ULP-WGS) of cfDNA in UM and associated clinical outcomes. MATERIALS AND METHODS ULP-WGS of cfDNA was performed on 29 plasma samples from 16 patients, 14 metastatic UM (mUM) and two non-metastatic, including pre- and post-treatment mUM samples from 10 patients treated with immunotherapy and one with liver-directed therapy. We estimated tumor fraction (TFx) and detected copy-number alterations (CNAs) using ichorCNA. Presence of 8q amplification was further analyzed using the likelihood ratio test (LRT). RESULTS Eleven patients with mUM (17 samples) of 14 had detectable circulating tumor DNA (ctDNA). 8q gain was detected in all 17, whereas monosomy 3 was detectable in 10 of 17 samples. TFx generally correlated with disease status, showing an increase at the time of disease progression (PD). 8q gain detection sensitivity appeared greater with the LRT than with ichorCNA at lower TFxs. The only patient with mUM with partial response on treatment had a high pretreatment TFx and undetectable on-treatment ctDNA, correlating with her profound response and durable survival. CONCLUSION ctDNA can be detected in mUM using ULP-WGS, and the TFx correlates with DS. 8q gain was consistently detectable in mUM, in line with previous studies indicating 8q gains early in primary UM and higher amplification with PD. Our work suggests that detection of CNAs by ULP-WGS, particularly focusing on 8q gain, could be a valuable blood biomarker to monitor PD in UM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Broad Institute of MIT and Harvard, Boston, MA.
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
- Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA.
- Genentech, San Francisco, CA.
- Dana Farber Cancer Institute, Boston, MA.
- Department of Surgery MD, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
ORCID-Profile: Kamaneh Montazeri, Evangelos S Gragoudas, Anne Marie Lane, Justine V Cohen, Genevieve M Boland, Christopher Kachulis, Mark Fleharty, Viktor A Adalsteinsson, Ryan J Sullivan, Ivana K Kim
Zitieren
APA
Sato, T., Montazeri, K., Gragoudas, E. S., Lane, A. M., Aronow, M. B., Cohen, J. V., Boland, G. M., Banks, E., Kachulis, C., Fleharty, M., Cibulskis, C., Lawless, A., Adalsteinsson, V. A., Sullivan, R. J., & Kim, I. K. (2024). Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma. JCO Precision Oncology. https://doi.org/10.1200/po.23.00368
Vancouver
Sato T, Montazeri K, Gragoudas ES, Lane AM, Aronow MB, Cohen JV, et al. Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma. JCO Precision Oncology. 2024. doi:10.1200/po.23.00368
BibTeX
@article{Sato2024,
author = {Sato, Takuto and Montazeri, Kamaneh and Gragoudas, Evangelos S and Lane, Anne Marie and Aronow, Mary Beth and Cohen, Justine V and Boland, Genevieve M and Banks, Eric and Kachulis, Christopher and Fleharty, Mark and Cibulskis, Carrie and Lawless, Aleigha and Adalsteinsson, Viktor A and Sullivan, Ryan J and Kim, Ivana K},
title = {Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.23.00368}
}
EUVIMED